financetom
Business
financetom
/
Business
/
Wyndham Hotels & Resorts Insider Sold Shares Worth $1,349,850, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Wyndham Hotels & Resorts Insider Sold Shares Worth $1,349,850, According to a Recent SEC Filing
Nov 3, 2024 12:16 PM

03:18 AM EDT, 10/28/2024 (MT Newswires) -- Michele Allen, Chief Financial Officer and Head of Strategy, on October 25, 2024, sold 15,000 shares in Wyndham Hotels & Resorts ( WH ) for $1,349,850. Following the Form 4 filing with the SEC, Allen has control over a total of 78,261 shares of the company, with 78,206 shares held directly and 55 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1722684/000143774924032170/xslF345X05/rdgdoc.xml

Price: 90.00, Change: -0.63, Percent Change: -0.70

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Jamf to Acquire Identity Automation
Jamf to Acquire Identity Automation
Mar 3, 2025
05:34 PM EST, 03/03/2025 (MT Newswires) -- Jamf ( JAMF ) said Monday it agreed to purchase Identity Automation for about $215 million in cash. Identity Automation provides an advanced identity and access management platform designed for industries like education and healthcare, where roles frequently change, the company said. The deal is set to close by the end of fiscal...
Citigroup nearly shifted $6 billion to wealth account, Bloomberg reports
Citigroup nearly shifted $6 billion to wealth account, Bloomberg reports
Mar 3, 2025
March 3 (Reuters) - Citigroup ( C/PN ) almost shifted about $6 billion to a customer's account by accident after a staffer handling the transfer copied and pasted the account number into a field for the dollar figure, Bloomberg News reported on Monday, citing people familiar with the matter. ...
Amneal, mAbxience's Biologics Licensing Application for Denosumab Biosimilars Accepted for Review by FDA
Amneal, mAbxience's Biologics Licensing Application for Denosumab Biosimilars Accepted for Review by FDA
Mar 3, 2025
05:33 PM EST, 03/03/2025 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) and Fresenius Kabi's mAbxience unit said Monday that the US Food and Drug Administration accepted for review their biologics licensing application for two proposed denosumab biosimilars. Denosumab is a monoclonal antibody that inhibits bone resorption and is used to treat conditions such as osteoporosis and bone metastases from...
SelectQuote Closes $350 Million Investment From Private Equity Firms
SelectQuote Closes $350 Million Investment From Private Equity Firms
Mar 3, 2025
05:38 PM EST, 03/03/2025 (MT Newswires) -- SelectQuote ( SLQT ) said Monday it closed a $350 million investment from funds managed by Bain Capital, Morgan Stanley Private Credit, and Newlight Partners. The company used $260 million of proceeds to pay down a term loan and has more than $100 million of available liquidity. As part of the transaction, SelectQuote...
Copyright 2023-2026 - www.financetom.com All Rights Reserved